Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Can Collaboration Close Biopharma's Talent Gap For Good?
Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.
-
If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?
Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?
-
Industry Innovators: APAC's Sharp Advanced Therapeutics Edge
APAC is rapidly advancing its role in the global therapeutics landscape, fueled by faster development models. Learn how this momentum is reshaping expectations for innovation and commercialization.
-
Patented Process For Intermediates Useful For Etrasimod Arginine
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Patented Process For Intermediates Useful For Deucravacitinib
Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Method Development For Forced Degradation Of GLP-1 Agonist
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
Enhancing Drug Performance Through Lipid-Based Formulations For CNS Indication
Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.
-
ddPCR Workflows For Gene Expression Analysis
RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.
-
Delving Into Gene Expression Data Analysis And Experimental Reproducibility
Scientific reproducibility is essential for credible research. Learn to navigate standardized frameworks, refine normalization techniques, and ensure your data remains transparent and verifiable.
FORMULATION DEVELOPMENT SOLUTIONS
- Advancing Nitrosamine Testing For Evolving Regulations
- Peptide Development Strategies
- High Potency Handling Capabilities And Support
- Emulate Contract Research Services
- Preparative Chromatography System Intended For Method And Process Development
- HyClone™ Prime Expression Medium
- Co-Crystal Prediction Service
- Duodenum Intestine Bio-Kit
- Keep A Close Eye On Quality With Excipients For Drug Formulation
- Oligonucleotide CDMO: From Preclinical To Commercial
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- TerraPower Isotopes Announces Plans To Build New cGMP Drug Manufacturing Facility In Philadelphia
- Experience Safer Pharmaceutical Processing With Esco Lifesciences At INTERPHEX 2026
- Discover Safer, Smarter Pharmaceutical Processing With Esco Lifesciences
- Axplora Announces $60 Million High Potency API Manufacturing Facility Expansion In Italy
- METTLER TOLEDO Launches New eGuide To Help Food Manufacturers Prevent Physical Contamination
- BD Announces $110 Million To Support U.S. Pharmaceutical Supply Chain For Biologic Drugs
- BD And Ypsomed Expand Partnership To Address Rapidly Growing Biologics Market
- ROSS PDDM-10 Planetary Dual Disperser Delivers Unmatched Pilot-Scale Processing Flexibility
- Emerson Streamlines Life Sciences Recipe Creation For Faster Time To Market
- Forma Life Sciences Launches U.S. Based Contract Development And Manufacturing Organization (CDMO) For Oral Solid Dosage Development And Commercial Manufacturing In Irvine, California